Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 6:10:e71420.
doi: 10.7554/eLife.71420.

Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome

Affiliations

Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome

Luka Bacic et al. Elife. .

Abstract

The chromatin remodeler ALC1 is recruited to and activated by DNA damage-induced poly(ADP-ribose) (PAR) chains deposited by PARP1/PARP2/HPF1 upon detection of DNA lesions. ALC1 has emerged as a candidate drug target for cancer therapy as its loss confers synthetic lethality in homologous recombination-deficient cells. However, structure-based drug design and molecular analysis of ALC1 have been hindered by the requirement for PARylation and the highly heterogeneous nature of this post-translational modification. Here, we reconstituted an ALC1 and PARylated nucleosome complex modified in vitro using PARP2 and HPF1. This complex was amenable to cryo-EM structure determination without cross-linking, which enabled visualization of several intermediate states of ALC1 from the recognition of the PARylated nucleosome to the tight binding and activation of the remodeler. Functional biochemical assays with PARylated nucleosomes highlight the importance of nucleosomal epitopes for productive remodeling and suggest that ALC1 preferentially slides nucleosomes away from DNA breaks.

Keywords: ALC1/CHD1L; PARP1; chromatin; chromosomes; gene expression; human; molecular biophysics; nucleosome; poly(ADP-ribose)ylation; remodeling; structural biology.

PubMed Disclaimer

Conflict of interest statement

LB, GG, AS, LL, KB, DD, MH, GH none, SB is co-founder and VP Science Strategy at Artios Pharma Ltd, SD Reviewing editor, eLife

Figures

Figure 1.
Figure 1.. Identification of an ALC1-PARylated nucleosome complex suitable for cryo-EM.
(A) Top: schematic of ALC1 constructs used in EMSA experiments. The arginine anchor residue R611, previously shown to interact with the nucleosome acidic patch, is indicated. Bottom: EMSA analysis of the complexes formed by different constructs of ALC1 and a 5’P-10-N-10 nucleosome in absence or presence of PAR chains deposited by PARP2 and HPF1. (B) Nucleosome sliding assay of 10 nM nucleosomes by 31.3 nM ALC1fl, performed after PARylation by 80 nM of PARP1 with 25 µM NAD+ in the absence (teal) and presence (orange) of 20 nM of HPF1. (C) Preparation and native PAGE analysis of the complex between ALC1fl and a PARylated nucleosome for cryo-EM (see Materials and methods).
Figure 1—figure supplement 1.
Figure 1—figure supplement 1.. Nucleosome sliding assay replicated as shown in Figure 1B.
The PARylation reactions were scaled up prior to the sliding assay (left), which allowed the rest of the reaction products to be subjected to western blotting (right).
Figure 1—figure supplement 2.
Figure 1—figure supplement 2.. Nucleosome sliding assays with 5 min (orange) or 30 min (brown) incubation time of the PARylation reaction prior to the initiation of the sliding reaction.
Superimposition of the sliding curves indicates that the PARylated nucleosome substrate is functionally identical between the two reactions, and therefore that 5 min of incubation is enough for the PARylation reaction to generate an optimal substrate for ALC1.
Figure 1—figure supplement 3.
Figure 1—figure supplement 3.. SDS–PAGE and Western blot analysis of different PARylation conditions of nucleosomes by PARP1/HPF1 or PARP2/HPF1.
Figure 1—figure supplement 4.
Figure 1—figure supplement 4.. Screening micrographs of complexes prepared with ALC1 and nucleosomes either unmodified (left), PARylated by PARP1 and HPF1 (middle), or PARylated by PARP2 and HPF1 (right).
Figure 2.
Figure 2.. Cryo-EM structure of the complex between a PARylated nucleosome and ALC1 in its active state.
(A) Cryo-EM map of the complex between a PARylated nucleosome and ALC1 in the state tightly bound to SHL2 and the H4 tail. The map is shown at a contour level of 0.15 and colored by chain assignment (H3 in blue, H4 in green, H2A in yellow, H2B in red, DNA in gray, and ALC1 in pink). The black ellipse in the dyad view indicates the nucleosome dyad axis. Superhelical locations 0 (dyad), 1, and 3 and the location of the acidic patch are indicated. (B) Atomic model of the complex between a PARylated nucleosome and ALC1 in the state tightly bound to SHL2 and the H4 tail. Same views and same color code as in (A). The black ellipse in the dyad view indicates the nucleosome dyad axis. (C) Same cryo-EM map as in (A), displayed at the same contour level, but in two different orientations, showing the H4 tail interacting with the C-terminal ATPase domain of ALC1. Same color code as in (A). (D) Close-up view of the boxed region in (C). (E) Atomic model shown in the same two orientations as in (C). In addition to the same color code as in (A), the cryo-EM density of the H4 tail is shown as a turquoise transparent surface, at the same contour level as in (A), (C), and (D). (F) Close-up view of the boxed region in (E).
Figure 2—figure supplement 1.
Figure 2—figure supplement 1.. Overview of cryo-EM data processing and analysis.
Figure 2—figure supplement 2.
Figure 2—figure supplement 2.. Superimposition of previous structures of remodeler-nucleosome complexes to our structure of the ALC1-nucleosome complex.
ALC1 is colored in two shades of pink as in Figure 2. For clarity, only the ATPase motor is shown for structures also containing other domains.
Figure 2—figure supplement 3.
Figure 2—figure supplement 3.. Close-up view of the structure of the complex between a PARylated nucleosome and ALC1 in the tightly bound state, showing the H4 tail interacting with the C-terminal ATPase domain of ALC1.
The same part of the complex is shown as in Figure 2F, with two residues from ALC1, D377, and D381, shown as gray sticks.
Figure 3.
Figure 3.. Dynamics of the ATPase domain of ALC1.
(A) Left: consensus map from 3D refinement in RELION of 43,698 particles, displayed at a contour level of 0.015 and in disc view. Regions of the map assigned to an interaction with the nucleosome acidic patch and to the macro domain are labeled. Right: UMAP visualization of the latent variable distribution of these same 43,698 particle images after training of an 8-dimensional latent variable model with cryoDRGN. Dots indicate all latent space coordinates that are part of the calculated graph traversal, labeled red dots indicate coordinates of maps shown in panels (B) – (G). Black lines are a visual guide and do not represent actual connectivity of the graph traversal. (BG) Maps sampled at representative steps along the graph traversal shown in (A). All maps are displayed at a contour level of 0.025 and in gyres view.
Figure 3—figure supplement 1.
Figure 3—figure supplement 1.. UMAP visualizations of the latent variable distributions from three replicate training runs of cryoDRGN with independent initializations, and with the indicated image size, pixel size, network architecture, and dimensionality of the latent variable.
Figure 3—figure supplement 2.
Figure 3—figure supplement 2.. Atomic model of auto-inhibited ALC1 (PDB 7EPU) rigid-body fitted into one of the maps from cryoDRGN with an open conformation of the ATPase motor.
The N-ATPase lobe is colored yellow, the C-ATPase lobe is colored red. For clarity, the macro domain, linker, and single-chain antibody are not displayed.
Figure 3—figure supplement 3.
Figure 3—figure supplement 3.. Distribution of Z values from a one-dimensional latent variable training run of cryoDRGN.
Maps generated by evaluating the decoder at Z values of the distribution’s peaks are shown.
Figure 4.
Figure 4.. Dynamics of the acidic patch interacting region and macro domain of ALC1.
(A) Left: consensus map from 3D refinement in RELION of 43,698 particles, displayed at a contour level of 0.015 and in disc view. Regions of the map assigned to an interaction with the nucleosome acidic patch and to the macro domain are labeled (same panel as in Figure 3A). Right: same plot as in Figure 3A but sampling different steps along the same graph traversal. Dots indicate all latent space coordinates that are part of the calculated graph traversal, labeled red dots indicate coordinates of maps shown in panels (B) – (G). Black lines are a visual guide and do not represent actual connectivity of the graph traversal. (B) – (G) Maps sampled along the graph traversal shown in (A). All maps are displayed at a contour level of 0.013 and in disc view.
Figure 4—figure supplement 1.
Figure 4—figure supplement 1.. UMAP visualization of the latent variable distribution from a replicate training run of cryoDRGN with independent initialization and with the indicated image size, pixel size, network architecture, and dimensionality of the latent variable.
The map displayed on the right was produced by evaluating the decoder at the Z values indicated by the red dot in the UMAP distribution.
Figure 5.
Figure 5.. ALC1 kinetics in nucleosome sliding and ATPase assays.
(A) Left: schematic of asymmetric nucleosomes PARylated by PARP1 with and without HPF1. Right: adding ALC1 and ATP to the PARylated FRET-labeled nucleosome results in sliding the histone octamer away from the short linker DNA end, resulting in a decrease of FRET. (B) Saturation curves of nucleosome sliding rates for 10 nM WT nucleosomes versus varying concentrations of ALC1fl. Nucleosome sliding assays were performed after PARylation by 80 nM PARP1 with 25 µM NAD+ in the absence (teal) or presence (orange) of 20 nM of HPF1. Points and error bars represent the mean and standard deviation, respectively, from three independent experiments. (C) Saturation curve of nucleosome sliding rates for 10 nM WT nucleosomes versus varying concentrations of ALC1fl R611A/S612A. Nucleosome sliding assays were performed after PARylation by 80 nM PARP1 and 20 nM HPF1 with 25 µM NAD+. Points and error bars represent the mean and standard deviation, respectively, from three independent experiments. (D, E) Saturation curves of nucleosome sliding rates for 10 nM APM (D) and gH4 (E) nucleosomes versus varying concentrations of ALC1fl. Nucleosome sliding assays were performed after PARylation by 80 nM PARP1 and 20 nM HPF1 with 25 µM NAD+. Points and error bars represent the mean and standard deviation, respectively, from three independent experiments. (F) ATPase activity for 2 µM ALC1fl (teal, orange, and green) or ALC1fl R611A/S612A (blue) in the presence of 250 nM 10-N-10 WT nucleosomes (teal, orange, and blue) or 10-N-10 gH4 nucleosomes (green), activated by PARylation by PARP1 with (orange, blue, and green) or without HPF1 (teal). Bars and error bars represent the mean and standard deviation, respectively, from three independent experiments.
Figure 5—figure supplement 1.
Figure 5—figure supplement 1.. A simplistic model to reproduce the observed deviation from Michaelis-Menten kinetics.
Reaction diagram of a tentative model (left) and resulting simulated saturation curve (right) for ALC1-catalyzed nucleosome sliding, where ALC1 first binds to the PARylated side of the nucleosome with a high affinity (K1), which results in fast unopposed sliding towards the longer linker (V1). ALC1 then binds to the other side of the nucleosome, which opposes sliding toward the longer linker and results in slower remodeling rate (V2). See Materials and methods section for further details.
Figure 5—figure supplement 2.
Figure 5—figure supplement 2.. Saturation curve shown in Figure 5C (blue) overlaid with the curve for wild-type ALC1 shown in Figure 5B (orange).
Same data and color code as in Figure 5.
Figure 5—figure supplement 3.
Figure 5—figure supplement 3.. Saturation curve shown in Figure 5D (red) overlaid with the curve for wild-type ALC1 shown in Figure 5B (orange).
Same data and color code as in Figure 5.
Figure 5—figure supplement 4.
Figure 5—figure supplement 4.. Saturation curve shown in Figure 5E (green) overlaid with the curve for wild-type ALC1 shown in Figure 5B (orange).
Same data and color code as in Figure 5.
Figure 5—figure supplement 5.
Figure 5—figure supplement 5.. Continuous kinetic assay to measure ATP consumption.
Left: schematic of the ATPase assay used in this study. Right: Raw data curves for control ATPase assays. The assay produces NAD+, which is the substrate of PARP1. We therefore include the PARP inhibitor Olaparib in our ATPase assays, to avoid further PARylation during the assay. See Materials and methods for details.
Figure 6.
Figure 6.. Model for the recognition of a PARylated nucleosome by ALC1.
Upon DNA damage, PARP1 or PARP2 and HPF1 deposit PAR chains on histones, causing the rapid recruitment of proteins containing PAR reader domains. Among these proteins, ALC1 selectively binds to PAR chains with its macro domain and recognizes the closest nucleosome by probing its acidic patch. Once the macro domain and linker region of ALC1 jointly recognize a PARylated nucleosome, the ATPase motor is released from their auto-inhibitory effect and can tightly bind to the nucleosomal DNA at SHL2 for productive remodeling. Preferential PARylation of target sites spatially closest to the DNA break causes preferential recruitment of ALC1 on the side of the nucleosome such that remodeling slides this nucleosome away from the break. By setting directionality in remodeling, this mechanism could promote exposure of the lesion to downstream repair factors.
Author response image 1.
Author response image 1.. Four ab initio models generated from a random subset of 50 000 particles taken from the particles retained after 2D classification.
Top row shows models in disc view, bottom row shows the same models in gyres view.
Author response image 2.
Author response image 2.. Synthetic 3D reference used to prime 3D classification.
This reference was generated from an atomic model of a free nucleosome (PDB entry 3LZ0) with a low-pass filter to 30 Å resolution. The model is shown in dyad view (left), disc view (center) and gyres view (right).
Author response image 3.
Author response image 3.. Ab initio model generated from the 43 698 particles after removal of their Euler angles.
The model is shown in dyad view (left), disc view (center) and gyres view (right).
Author response image 4.
Author response image 4.. Map from 3D refinement of the 43 698 particles primed with the ab initio model in Author response image 3.
This map is shown at the same contour level as the map in Figure 3A.

Similar articles

Cited by

References

    1. Abbott JM, Zhou Q, Esquer H, Pike L, Broneske TP, Rinaldetti S, Abraham AD, Ramirez DA, Lunghofer PJ, Pitts TM, Regan DP, Tan AC, Gustafson DL, Messersmith WA, LaBarbera DV. First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer. Molecular Cancer Therapeutics. 2020;19:1598–1612. doi: 10.1158/1535-7163.MCT-20-0106. - DOI - PMC - PubMed
    1. Afonine PV, Poon BK, Read RJ, Sobolev OV, Terwilliger TC, Urzhumtsev A, Adams PD. Real-space refinement in PHENIX for cryo-em and crystallography. Acta Crystallographica. Section D, Structural Biology. 2018;74:531–544. doi: 10.1107/S2059798318006551. - DOI - PMC - PubMed
    1. Ahel D, Horejsí Z, Wiechens N, Polo SE, Garcia-Wilson E, Ahel I, Flynn H, Skehel M, West SC, Jackson SP, Owen-Hughes T, Boulton SJ. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science. 2009;325:1240–1243. doi: 10.1126/science.1177321. - DOI - PMC - PubMed
    1. Anderson CJ, Baird MR, Hsu A, Barbour EH, Koyama Y, Borgnia MJ, McGinty RK. Structural basis for recognition of ubiquitylated nucleosome by Dot1l methyltransferase. Cell Reports. 2019;26:1681–1690. doi: 10.1016/j.celrep.2019.01.058. - DOI - PMC - PubMed
    1. Armache KJ, Garlick JD, Canzio D, Narlikar GJ, Kingston RE. Structural basis of silencing: SIR3 BAH domain in complex with a nucleosome at 3.0 å resolution. Science. 2011;334:977–982. doi: 10.1126/science.1210915. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources